Breast diseases do not always mean breast cancer. Lake Charles Memorial’s
Breast Health Program uses 3D digital mammography, breast sonography,
and 3D breast MRI’s to determine the type and location of a breast
mass or lesion.
Most women experience breast changes at some time in their lives. Age,
hormone levels, and medicines may cause lumps, bumps, and discharges (fluids
that are not breast milk). Minor and serious breast problems have similar
symptoms. Although cancer is always our first concern, many breast problems
are not cancer. Memorial’s Breast Health Program can treat:
- Intraductal papillomas
- Sclerosing adenosis
- Radial scars
- Breast cancer
With minimally invasive techniques such as stereotactic breast biopsy and
intact breast biopsy to assess a breast abnormality, our specialized team
of radiologists, pathologists, gynecologists, radiation oncologists, medical
oncologists, and technologists provide diagnosis and treatment options
based on your particular diagnosis. Our surgeons also employ the technique
of sentinel node biopsy, which uses cutting-edge, pinpoint accuracy to
remove the first few lymph nodes into which a tumor drains. And although
breast abnormalities aren’t always cancer-related, should more advanced
treatment be necessary, our cancer center offers the latest therapies,
including complex 4D cancer fighting technology such as intensity modulated
radiation therapy (IMRT) and accelerated partial breast radiotherapy (APBR),
as well as customized chemotherapy drugs based on the type and phase of
cancer. We also employ a certified lymphedema specialist to assist in
prevention, diagnosis and treatment of lymphedema.
Commission on Cancer Accredited
Like every major national cancer center, Lake Charles Memorial Cancer Center
is accredited by the Commission on Cancer (CoC) of the American College
of Surgeons (ACoS). CoC accreditation assures that a cancer program meets
or exceeds 34 CoC nationally-recognized quality care standards and maintains
levels of excellence in the delivery of comprehensive patient-centered
care. Like all CoC-accredited facilities, Memorial maintains a cancer
registry and contributes data to the National Cancer Data Base (NCDB),
a joint program of the CoC and American Cancer Society (ACS). Data on
all types of cancer are tracked and analyzed through the NCDB and used
to explore trends in cancer care.
Genuis 3D Digital Mammography: Genius™ 3D Mammography views each layer of the breast like the pages
of a book for more thorough imaging of breasts of all shapes, sizes and
densities. It scans all the complexities of the breast tissue in greater
detail which allows better evaluation of the breast tissue layer by layer,
making fine details more visible and no longer hidden by overlapping tissue.
Ultrasound: An ultrasound following a standard mammogram increases detection of breast
cancers that are small. Sound waves look inside the breast with powerful
ultrasound technology giving a more realistic view of the whole breast,
its physical structures while providing multiple views. It helps distinguish
normal findings like cysts or fat lobules from suspicious breast changes
that need biopsy.
Magseed: Most surgeries to remove a breast tumor use a “wire localization”
procedure where a wire is inserted into the tumor serving as a road map
for the breast surgeon to remove the diseased tissue. A new option called
Magseed is smaller than a grain of rice and can be placed into a tumor
up to 30 days before the patient’s surgery. It produces no discomfort,
rarely moves and stays within the breast. During surgery, a magnetic probe
detects the Magseed, guiding the surgeon to the tumor. The outcome is
a better cosmetic result and a more accurate removal of cancerous tissue.
Intensity Modulated Radiation Therapy
Accelerated Partial Breast Radiotherapy: Accelerated Partial Breast Radiation (APBR) focuses specifically on the
part of the breast where the tumor was removed, so radiation is contained
to the tumor cavity as much as possible. It affects less of the healthy
tissue and organs close to the breasts, including the lungs and heart.
APBR often reduces the length of treatment for breast cancer. Requirements
typically include a small tumor, clear surgical margins after a lumpectomy
and preferably no lymph nodes containing cancer making it a suitable treatment
option for women with early stage breast cancer.
3D Stereotactic Breast Biopsy: Using a local anesthesia to reduce discomfort, this image-guided biopsy
is able to remove several cores of sample tissue and used most often when
a distinct lump can’t be felt, but an abnormality is seen on a mammogram.
A needle is guided to the suspicious location with the help of 3D stereotactic
imaging technology. A small metal clip may be put into the breast to mark
where the biopsy sample was taken in case the tissue is cancerous and
surgery is needed.
Intact Breast Biopsy: Intact Breast Lesion Excision System is a minimally invasive excision
performed at the time of biopsy on high-risk breast lesions using ultrasound
and stereotactic guidance in place of conventional surgery. High-risk
breast lesions are labeled as such because they have an elevated chance
of becoming cancerous, prompting many patients to opt for their swift
removal. The intact biopsy uses local anesthesia and a small incision
to completely remove all suspect tissue. Recovery time is quicker with
far less physical discomfort.
Sentinel Node Biopsy: Sentinel node biopsy is a surgical procedure used to determine whether
cancer has spread beyond a primary tumor into the lymphatic system. The
sentinel nodes are the first few lymph nodes into which a tumor drains.
Prior to the surgery, the radiologist injects tracer material that helps
the surgeon locate and remove the sentinel nodes during surgery. Under
general anesthesia, a small incision is made in the area over the lymph
nodes. During the procedure, the sentinel nodes that are removed are then
sent to a pathologist to examine for signs of cancer.
Breast-conserving Lumpectomy: Breast-Conserving Lumpectomy removes the tumor as well as a small, clear
(cancer-free) margin of healthy tissue around it while leaving as much
normal breast as possible. Some surrounding healthy tissue and lymph nodes
may be removed. How much of the breast is removed depends on the size
and location of the tumor and other factors. Most of the breast remains.
For those with early stage breast cancer this may be an option. Follow-up
radiation therapy to the remaining breast tissue is generally recommended.
Chemotherapy: Depending on the stage and molecular characteristics of the cancer, chemotherapy
or targeted therapy (including hormone therapy) may be part of the treatment.
Our medical oncology team customizes chemotherapies based on the patient
and the specifics of the cancer using complex drugs to destroy cancer
cells by stopping their ability to grow and divide. Chemotherapy is generally
given after surgery to lower the risk of recurrence or sometimes before
surgery to shrink the tumor.
Immunotherapy: When paired with chemotherapy, immunotherapy is changing the treatment
of cancer by harnessing the body's natural strength to fight cancer—empowering
the immune system to conquer more types of cancer. It uses substances
made by the body or in a laboratory to improve immune system function
which can help make the cancer cells more receptive to chemotherapy drugs.
Genetic testing: For breast cancer, there are two groups of patients that may benefit from
genetic testing: Patients who have breast cancer in their family, where
suspicion is high for inherited breast cancer risk, even if they have
never had breast cancer personally or patients who currently have breast
cancer for whom chemotherapy would be recommended if the tumor has a high
risk of recurrence based on a genetic test.
Hereditary Genetic Testing: BReast
CAncer (BRCA) susceptibility genes are the most common inherited breast cancer
genes. BRCA genetic testing is a blood test ordered by a physician, drawn
in our lab and sent to a specialized lab that uses DNA analysis to identify
harmful changes (mutations) in either one of the two inherited breast
cancer susceptibility genes. Mutations to either breast cancer gene —
BRCA1 or BRCA2 — increase the risk of developing breast cancer when
compared with the cancer risk of a people without a BRCA gene mutation.
A positive result may increase risk of other cancer types as well.
Recurrence Risk Genetic Testing: This genetic test may be recommended in a patient with a current breast
cancer diagnosis to determine risk of late recurrence. This is a blood
test ordered by a physician, drawn in our lab and sent to a specialized
lab that uses DNA analysis to identify harmful changes (mutations) in
a large panel of genes, which increase the risk of breast cancer recurrence.
A positive result may indicate the need for chemotherapy.
Oncology Certified Nurses: Nurses who obtain certification by the Oncology Nursing Certification
Corporation (ONCC) provide tangible evidence that nurses have the knowledge
required to effectively provide care to patients experiencing the complex
problems associated with a diagnosis of cancer. Currently, 43% of our
oncology registered nurses system-wide are certified by the ONCC with
100% of our main campus chemotherapy nurses certified.
Cancer Patient Navigator &
View our comprehensive Breast Health Brochure here.
Memorial Breast Health Oak Park Campus
1701 Oak Park Blvd., Lake Charles
Memorial for Women Breast Health
1900 Gauthier Rd., Lake Charles